Abstract
Fibromyalgia (FM) is a chronic condition involving widespread pain and usually fatigue and/or sleep problems. It can significantly decrease patients’ quality of life, and is often overlooked in older patients with other painful conditions. Education and exercise are key to FM management, with non-pharmacological options like cognitive behavioural therapy and physical therapy added as required. Pharmacological therapy should target depression, pain or sleep problems that persist despite other interventions.
Similar content being viewed by others
References
Sarzi-Puttini P, Giorgi V, Marotto D, et al. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645–60.
Minerbi A, Fitzcharles M-A. Fibromyalgia in older individuals. Drugs Aging. 2021;38(9):735–49.
Arnold LM. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611–28.
Bair MJ, Krebs EE. Fibromyalgia. Ann Intern med. 2020;172(5):ITC33-ITC48.
National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. 2021. https://www.nice.org.uk. Accessed 8 Aug 2022.
Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–28.
Estévez-López F, Maestre-Cascales C, Russell D, et al. Effectiveness of exercise on fatigue and sleep quality in fibromyalgia: a systematic review and meta-analysis of randomized trials. Arch Phys Med Rehabil. 2020;102(4):752–61.
Franco KFM, Lenior D, Dos Santos Franco YR, et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: a systematic review with meta-analysis. Eur J Pain. 2021;25(1):51–70.
Antcliff D, Campbell M, Woby S, et al. Activity pacing is associated with better and worse symptoms for patients with long-term conditions. Clin J Pain. 2017;33(3):205–14.
Karsdorp PA, Vlaeyen JW. Active avoidance but not activity pacing is associated with disability in fibromyalgia. Pain. 2009;147(1):29–35.
Elma Ö, Yilmaz ST, Deliens T, et al. Do nutritional factors interact with chronic musculoskeletal pain? A systematic review. J Clin Med. 2020;9(3):702.
Lowry E, Marley J, McWeigh JG, et al. Dietary interventions in the management of fibromyalgia: a systematic review and best-evidence synthesis. Nutrients. 2020;12(9):2664.
Bernardy K, Klose P, Welsch P, et al. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2018;22(2):242–60.
Lumley MA, Schubiner H, Lockhart NA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. Pain. 2017;158(12):2354–63.
Deare JC, Zheng Z, Xue CCL, et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013;2013(5):CD007070.
Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;9(9):CD011790.
Cooper TE, Derry S, Wiffen PJ, et al. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD012188.
Welsch P, Uceyler N, Klose P, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018;2(2):CD010292.
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):675-94.
Shering Corporation. Mirtazapine: US prescribing information. 2007. https://www.accessdata.fda.gov. Accessed 8 Aug 2022.
Walitt B, Klose P, Uceyler N, et al. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016(6):CD011804.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The preparation of this review was not supported by any external funding.
Authorship and conflict of interest
C. Fenton, a contracted employee of Adis International Ltd/Springer Nature, and C. Kang, a salaried employee of Adis International Ltd/Springer Nature, declare no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.
Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability
Not applicable.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fenton, C., Kang, C. Consider fibromyalgia in older patients with chronic widespread pain. Drugs Ther Perspect 38, 394–399 (2022). https://doi.org/10.1007/s40267-022-00940-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-022-00940-8